TY - JOUR AU - Jemal, A. PY - 2005 DA - 2005// TI - Cancer statistics, 2005 JO - CA Cancer J Clin VL - 55 UR - https://doi.org/10.3322/canjclin.55.1.10 DO - 10.3322/canjclin.55.1.10 ID - Jemal2005 ER - TY - JOUR AU - Parkin, D. M. PY - 2005 DA - 2005// TI - Global cancer statistics, 2002 JO - CA Cancer J Clin VL - 55 UR - https://doi.org/10.3322/canjclin.55.2.74 DO - 10.3322/canjclin.55.2.74 ID - Parkin2005 ER - TY - STD TI - American gastroenterological association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology. 1999, 117 (6): 1463-84. ID - ref3 ER - TY - JOUR AU - Pitt, H. A. PY - 1995 DA - 1995// TI - Curative treatment for pancreatic neoplasms JO - Standard resection. Surg Clin North Am VL - 75 ID - Pitt1995 ER - TY - JOUR AU - Raraty, M. G. PY - 2002 DA - 2002// TI - New techniques and agents in the adjuvant therapy of pancreatic cancer JO - Acta Oncol VL - 41 UR - https://doi.org/10.1080/028418602321028184 DO - 10.1080/028418602321028184 ID - Raraty2002 ER - TY - JOUR AU - Schneider, G. PY - 2005 DA - 2005// TI - Pancreatic cancer: basic and clinical aspects JO - Gastroenterology VL - 128 UR - https://doi.org/10.1053/j.gastro.2005.04.001 DO - 10.1053/j.gastro.2005.04.001 ID - Schneider2005 ER - TY - JOUR AU - Morris, J. P. T. AU - Wang, S. C. AU - Hebrok, M. PY - 2010 DA - 2010// TI - KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2899 DO - 10.1038/nrc2899 ID - Morris2010 ER - TY - JOUR AU - Hezel, A. F. PY - 2006 DA - 2006// TI - Genetics and biology of pancreatic ductal adenocarcinoma JO - Genes Dev VL - 20 UR - https://doi.org/10.1101/gad.1415606 DO - 10.1101/gad.1415606 ID - Hezel2006 ER - TY - JOUR AU - Sato, N. AU - Goggins, M. PY - 2006 DA - 2006// TI - Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas JO - J Hepatobiliary Pancreat Surg VL - 13 UR - https://doi.org/10.1007/s00534-005-1056-2 DO - 10.1007/s00534-005-1056-2 ID - Sato2006 ER - TY - JOUR AU - Dammann, R. PY - 2003 DA - 2003// TI - Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206582 DO - 10.1038/sj.onc.1206582 ID - Dammann2003 ER - TY - JOUR AU - Gerdes, B. PY - 2003 DA - 2003// TI - Tumor-suppressing pathways in cystic pancreatic tumors JO - Pancreas VL - 26 UR - https://doi.org/10.1097/00006676-200301000-00008 DO - 10.1097/00006676-200301000-00008 ID - Gerdes2003 ER - TY - JOUR AU - Omura, N. PY - 2008 DA - 2008// TI - Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma JO - Cancer Biol Ther VL - 7 UR - https://doi.org/10.4161/cbt.7.7.6208 DO - 10.4161/cbt.7.7.6208 ID - Omura2008 ER - TY - JOUR AU - Perini, M. V. PY - 2008 DA - 2008// TI - Clinical and pathologic prognostic factors for curative resection for pancreatic cancer JO - HPB (Oxford) VL - 10 UR - https://doi.org/10.1080/13651820802140752 DO - 10.1080/13651820802140752 ID - Perini2008 ER - TY - JOUR AU - Raptis, D. A. PY - 2010 DA - 2010// TI - Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer JO - Surgeon VL - 8 UR - https://doi.org/10.1016/j.surge.2010.03.001 DO - 10.1016/j.surge.2010.03.001 ID - Raptis2010 ER - TY - JOUR AU - Peng, D. F. PY - 2005 DA - 2005// TI - Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas JO - Cancer Sci VL - 96 UR - https://doi.org/10.1111/j.1349-7006.2005.00071.x DO - 10.1111/j.1349-7006.2005.00071.x ID - Peng2005 ER - TY - JOUR AU - Fukushima, N. PY - 2003 DA - 2003// TI - Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice JO - Cancer Biol Ther VL - 2 UR - https://doi.org/10.4161/cbt.183 DO - 10.4161/cbt.183 ID - Fukushima2003 ER - TY - JOUR AU - Park, J. K. PY - 2012 DA - 2012// TI - The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer JO - Pancreas VL - 41 UR - https://doi.org/10.1097/MPA.0b013e318221c903 DO - 10.1097/MPA.0b013e318221c903 ID - Park2012 ER - TY - JOUR AU - Park, J. K. PY - 2007 DA - 2007// TI - Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer JO - Pancreas VL - 35 UR - https://doi.org/10.1097/MPA.0b013e318153fa42 DO - 10.1097/MPA.0b013e318153fa42 ID - Park2007 ER - TY - JOUR AU - Pfeifer, G. P. AU - Dammann, R. PY - 2005 DA - 2005// TI - Methylation of the tumor suppressor gene RASSF1A in human tumors JO - Biochemistry (Mosc) VL - 70 UR - https://doi.org/10.1007/s10541-005-0151-y DO - 10.1007/s10541-005-0151-y ID - Pfeifer2005 ER - TY - JOUR AU - Matsubayashi, H. PY - 2003 DA - 2003// TI - Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues JO - Clin Cancer Res VL - 9 ID - Matsubayashi2003 ER - TY - JOUR AU - Jiao, L. PY - 2007 DA - 2007// TI - K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking JO - Pancreas VL - 34 UR - https://doi.org/10.1097/01.mpa.0000246665.68869.d4 DO - 10.1097/01.mpa.0000246665.68869.d4 ID - Jiao2007 ER - TY - JOUR AU - Stafford, L. J. AU - Vaidya, K. S. AU - Welch, D. R. PY - 2008 DA - 2008// TI - Metastasis suppressors genes in cancer JO - Int J Biochem Cell Biol VL - 40 UR - https://doi.org/10.1016/j.biocel.2007.12.016 DO - 10.1016/j.biocel.2007.12.016 ID - Stafford2008 ER - TY - JOUR AU - Shevde, L. A. AU - Welch, D. R. PY - 2003 DA - 2003// TI - Metastasis suppressor pathways–an evolving paradigm JO - Cancer Lett VL - 198 UR - https://doi.org/10.1016/S0304-3835(03)00304-5 DO - 10.1016/S0304-3835(03)00304-5 ID - Shevde2003 ER - TY - JOUR AU - Mees, S. T. PY - 2009 DA - 2009// TI - Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas JO - Ann Surg Oncol VL - 16 UR - https://doi.org/10.1245/s10434-009-0531-4 DO - 10.1245/s10434-009-0531-4 ID - Mees2009 ER - TY - JOUR AU - Hotz, H. G. PY - 2003 DA - 2003// TI - An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer JO - Pancreas VL - 26 UR - https://doi.org/10.1097/00006676-200305000-00020 DO - 10.1097/00006676-200305000-00020 ID - Hotz2003 ER - TY - JOUR AU - Mardin, W. A. PY - 2010 DA - 2010// TI - SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-549 DO - 10.1186/1471-2407-10-549 ID - Mardin2010 ER - TY - JOUR AU - Vandesompele, J. PY - 2002 DA - 2002// TI - Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes JO - Genome biology VL - 3 UR - https://doi.org/10.1186/gb-2002-3-7-research0034 DO - 10.1186/gb-2002-3-7-research0034 ID - Vandesompele2002 ER - TY - JOUR AU - Hurst, D. R. PY - 2009 DA - 2009// TI - Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3559 DO - 10.1158/0008-5472.CAN-08-3559 ID - Hurst2009 ER - TY - JOUR AU - Szafranska, A. E. PY - 2007 DA - 2007// TI - MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210228 DO - 10.1038/sj.onc.1210228 ID - Szafranska2007 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/264/prepub UR - http://www.biomedcentral.com/1471-2407/13/264/prepub ID - ref30 ER -